𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Therapy of metastatic breast cancer with humanized antibodies against the HER2 receptor protein

✍ Scribed by G. Schaller; N. Bangemann; C. Becker; H. Bühler; F. Opri; H. K. Weitzel

Publisher
Springer-Verlag
Year
1999
Tongue
English
Weight
446 KB
Volume
125
Category
Article
ISSN
1432-1335

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Detection of antibodies against the cell
Detection of antibodies against the cellular protein p53 in sera from patients with breast cancer
✍ L. V. Crawford; D. C. Pim; R. D. Bulbrook 📂 Article 📅 1982 🏛 John Wiley and Sons 🌐 French ⚖ 658 KB

## Abstract Antibodies reacting with the host protein p53 were found in the sera of patients with primary or secondary carcinoma of the breast. Fourteen out of the 155 sera from breast cancer patients tested were positive for anti‐p53 antibodies (9%) and no positives were detected among 164 control

Her-2/neu and EGFR tyrosine kinase activ
Her-2/neu and EGFR tyrosine kinase activation predict the efficacy of trastuzumab-based therapy in patients with metastatic breast cancer
✍ Gernot Hudelist; Wolfgang J. Köstler; Klaus Czerwenka; Ernst Kubista; Johannes A 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 372 KB 👁 2 views

## Abstract Her‐2/__neu__ overexpression in human breast cancer leads to an aggressive biological behavior and poor prognosis. Although the anti‐Her‐2/__neu__ antibody trastuzumab (Herceptin®) has become a valuable therapeutic option for patients with Her‐2/__neu__‐overexpressing breast cancer, man